Martignone S, Ménard S, Bufalino R, Cascinelli N, Pellegrini R, Tagliabue E, Andreola S, Rilke F, Colnaghi M I
Division of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.
J Natl Cancer Inst. 1993 Mar 3;85(5):398-402. doi: 10.1093/jnci/85.5.398.
The 67-kd laminin receptor is a cell-surface protein that binds laminin with high affinity. In vitro studies suggest that this protein is involved in the progression of human tumors to invasive cancers (metastasis), but there have been few in vivo studies. Identification of such proteins would allow development of therapies aimed at interfering with their mechanisms of action.
This large retrospective study was designed to investigate the association of expression of this laminin receptor molecule with established prognostic factors and overall survival in breast carcinoma patients.
We immunohistochemically stained archival paraffin-embedded sections of 1160 primary breast carcinomas, using an immunoperoxidase technique and the MLuC5 monoclonal antibody, which is specific for the 67-kd laminin receptor. Specimens were obtained from consecutive surgeries performed from January 1968 through December 1971. Patients with negative lymph nodes or involved regional nodes had been treated with surgery alone; those with positive axillary nodes had received surgery and radiotherapy. No chemotherapy had been administered until disease recurrence. The statistical analysis was carried out using the logrank method for the survival curves and the actuarial life table to calculate survival rates according to the different prognostic variables.
We found statistically significant associations between laminin receptor expression and young age (P < .001), premenopausal status (P = .001), positive axillary lymph nodes (P = .01), peritumoral lymphatic invasion (P = .02), and the diameter of the tumor (P = .05). Moreover, the association of expression of the receptor protein with poor prognosis, as indicated by survival curves, was statistically significant (P < .01). For patients with receptor-negative tumors, the survival rate was 50% at 20 years; for those with receptor-positive tumors, the survival rate was 50% at 13 years. Multivariate analysis showed the laminin receptor to be an independent prognostic factor (P = .005), indicating its predictive value in relation to overall survival.
Our data suggest that the 67-kd laminin receptor is associated with the metastatic process.
These preliminary findings also suggest that hormones may have a regulatory role in the in vivo expression of the 67-kd laminin receptor, which supports the hypothesis that hormone therapy might inhibit expression of the receptor. Studies of expression of this receptor in tumors of patients with extremely different sex hormone levels (e.g., men and pregnant women) are in progress.
67kd层粘连蛋白受体是一种细胞表面蛋白,能与层粘连蛋白高亲和力结合。体外研究表明,该蛋白参与人类肿瘤向侵袭性癌症(转移)的进展,但体内研究较少。鉴定此类蛋白将有助于开发旨在干扰其作用机制的疗法。
这项大型回顾性研究旨在调查这种层粘连蛋白受体分子的表达与乳腺癌患者既定预后因素及总生存期之间的关联。
我们使用免疫过氧化物酶技术和对67kd层粘连蛋白受体具有特异性的MLuC5单克隆抗体,对1160例原发性乳腺癌的存档石蜡包埋切片进行免疫组织化学染色。标本取自1968年1月至1971年12月连续进行的手术。淋巴结阴性或区域淋巴结受累的患者仅接受了手术治疗;腋窝淋巴结阳性的患者接受了手术和放疗。在疾病复发前未进行化疗。使用对数秩检验法分析生存曲线,并使用精算生命表根据不同的预后变量计算生存率。
我们发现层粘连蛋白受体表达与年轻(P <.001)、绝经前状态(P =.001)、腋窝淋巴结阳性(P =.01)、肿瘤周围淋巴浸润(P =.02)以及肿瘤直径(P =.05)之间存在统计学上的显著关联。此外,生存曲线显示受体蛋白表达与预后不良之间的关联具有统计学意义(P <.01)。对于受体阴性肿瘤的患者,20年生存率为50%;对于受体阳性肿瘤的患者,13年生存率为50%。多变量分析显示层粘连蛋白受体是一个独立的预后因素(P =.005),表明其对总生存期具有预测价值。
我们的数据表明67kd层粘连蛋白受体与转移过程相关。
这些初步发现还表明激素可能在67kd层粘连蛋白受体的体内表达中具有调节作用,这支持了激素疗法可能抑制该受体表达的假说。目前正在对性激素水平差异极大的患者(如男性和孕妇)肿瘤中该受体的表达进行研究。